Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 2. Frequency of new molecular entities (NMEs, i.e. new drug candiddates) in inhibition-based drug-drug interactions (DDIs) with drugs approved by the Food and Drug Administration (FDA) in the United States between 2013 and 2016 (Yu et al., 2018). (A) Grouping by therapeutic class. (B) Grouping by enzymes involved. Pgp and OAT1B1 are transporters. COMT: catechol O-methyl transferase.
Biomolecules & Therapeutics 2022;30:1~18
© Biomolecules & Therapeutics